As of May 21
| +0.0008 / +0.19%|
The 3 analysts offering 12-month price forecasts for Intellipharmaceutics International Inc have a median target of 2.50, with a high estimate of 3.00 and a low estimate of 2.00. The median estimate represents a +487.68% increase from the last price of 0.43.
The current consensus among 3 polled investment analysts is to Buy stock in Intellipharmaceutics International Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.